Editorial |

Does Aquaporin-4–Seronegative Neuromyelitis Optica Exist?

Michael Levy, MD, PhD1
[+] Author Affiliations
1Department of Neurology, Johns Hopkins University, Baltimore, Maryland
JAMA Neurol. 2014;71(3):271-272. doi:10.1001/jamaneurol.2013.5865.
Text Size: A A A
Published online


With the improvement in anti–aquaporin-4 (AQP4) assay sensitivity to near 90%,1 the concept of seronegative neuromyelitis optica (NMO) is being challenged. The widely accepted criteria for NMO proposed2 in 1999 and revised3 in 2006 define NMO as a disease localized to the optic nerves and spinal cord, which is not multiple sclerosis (MS). The anti-AQP4 antibody has always been a very highly specific biomarker for NMO but, owing to insensitive assays, seropositivity was initially considered only a supportive criterion. Seronegative NMO was intended to represent the same disease process as seropositive NMO but, for whatever reason, the anti-AQP4 antibody was not detectable at the time. During the past 8 years since the anti-AQP4 antibody biomarker was discovered and linked to NMO, the research field has focused intensely on the role of AQP4 as an immunopathogenic target.4 Supported by incremental advancements in the anti-AQP4 biomarker assay, the understanding of true NMO is expanding its localization to brainstem and cortical disease, while narrowing its population base to those who are seropositive for the anti-AQP4 antibody.5 That leaves neuroimmunologists with the question of whether a seronegative NMO disease actually exists?

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles